Detalhe da pesquisa
1.
Combined with UPLC-Triple-TOF/MS-based plasma lipidomics and molecular pharmacology reveals the mechanisms of schisandrin against Alzheimer's disease.
Chin Med
; 18(1): 11, 2023 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36747236